Pēd. atjaunots: 22.07.2024 05:10 (GMT+3)

TSE: COMMITTEE'S DECISION ON FARMAATSIATEHAS

24.12.2003, Nasdaq Tallinn, TLN

Tallinna Börs NEWS RELEASE 12/24/2003

COMMITTEE'S DECISION ON FARMAATSIATEHAS

DECISION OF LISTING AND SURVEILLANCE COMMITTEE OF TALLINN STOCK EXCHANGE
ON VIOLATION OF INFORMATION DISCLOSURE REQUIREMENTS BY TALLINNA
FARMAATSIATEHASE AS

At its meeting of 18 December 2003, the Listing and Surveillance Committee of
the Tallinn Stock Exchange reviewed the circumstances identified and
materials collected in the course of supervisory proceedings carried out with
respect to Tallinna Farmaatsiatehase AS (hereinafter "Farmaatsiatehas").

Considering the materials submitted and having reviewed the explanations
given by the Farmaatsiatehas, the Listing and Surveillance Committee of the
Stock Exchange

concluded the following.

1. The Farmaatsiatehas should have disclosed the important materials
concerning the agenda of the special general meeting together with the notice
of the general meeting.

Therefore, we have to assume the position that the Farmaatsiatehas has not
fully performed the obligations arising from clauses 1.2.1, 2.4.1, and 7.2.1
of the "Requirements for Issuers" (hereinafter RI) part of the Rules and has
disclosed incomplete information. The Farmaatsiatehas has violated the
obligations set out in the RI, which require an issuer to disclose all the
important materials concerning the agenda of a general meeting. This
requirement can be classified as important, particularly considering the fact
that it was a special general meeting whose agenda included major
transactions with persons connected to the issuer. Compliance with the
requirements makes it possible to ensure that transactions are made in a
uniform manner and on the basis of publicly known information, thus securing
the lawfulness and regularity of trading and the transparency and reliability
of the market.

2. Violation by the Farmaatsiatehas of its obligations has been evidenced, as
assessed by the Listing and Surveillance Committee of the Stock Exchange, by
the circumstances identified in the course of the supervisory proceedings
carried out by the Stock Exchange.

3. There are no objective circumstances which would have prevented the
Farmaatsiatehas from duly and timely performing its obligations in the
disclosure of materials about the issues discussed at its special general
meeting.

4. There are sufficient grounds to apply the legal remedies within the
competence of the Stock Exchange to the Farmaatsiatehas.

Proceeding from the above, the committee concluded that the activities of the
Farmaatsiatehas have been contrary to the provisions of clauses 1.2.1, 2.4.1,
and 7.2.1 of the RI.

Based on the "Agreement on Listing Securities on Tallinn Stock Exchange"
concluded between the Stock Exchange and the Farmaatsiatehas and guided by
clauses 10.1 and 10.2 of the "Requirements for Issuers", clauses 4.1.2.1,
4.3.1, 4.8.1, and 4.8.2 of "Supervision", and clause 2.1 of "Rates of Fines"
of the TSE Rules, the Listing and Surveillance Committee of the Stock Exchange

decided:

to impose a fine of fifty thousand (50,000) kroons on the Farmaatsiatehas for
violation of clauses 1.2.1, 2.4.1, and 7.2.1 of the RI.

Furthermore, the Listing and Surveillance Committee of the Stock Exchange
once more calls the issuer’s attention to the need to perform its obligations
under the Rules more carefully.

The Listing Committee of the Stock Exchange also informs the Farmaatsiatehas
of its right to contest this decision of the Listing and Surveillance
Committee of the Stock Exchange and to refer the dispute for settlement to
the Tallinn Stock Exchange Arbitration Court. According to clause 4.8.4 of
the "Supervision" part of the TSE Rules, the filing of an action with the
Stock Exchange Arbitration Court does not exempt the Farmaatsiatehas from
payment of the fine by the deadline hereby set.

This decision is subject to disclosure according to the procedure set out in
clause 4.8.12 of the "Supervision" part of the TSE Rules.

The decision together with a summary of the supervisory proceedings conducted
by the Stock Exchange shall be forwarded to the Financial Supervision
Authority in accordance with clause 4.8.13 of the "Supervision" part of the
TSE Rules.


Tallinn Stock Exchange
Market Services
+372 640 8802

Vērtspapīri

Akcijas
Obligācijas
Ieguldījumu Fondi

Tirgus informācija

Statistika
Tirdzniecība
Indeksi
Izsoles

Noteikumi

Biržas noteikumi
Uzraudzība

Nāc uz Biržu

Uzņēmumiem
Investoriem
Biržas biedriem
First North konsultantiem

Aktualitātes

Nasdaq ziņas
Emitentu ziņas
Kalendārs

Par mums

Nasdaq Baltijas tirgus
Biroji